- Home
- MGPI vs PRTA Comparison
MGPI vs PRTA Comparison
Compare MGPI & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGPI
- PRTA
- Stock Information
- Founded
- MGPI 1941
- PRTA 2012
- Country
- MGPI United States
- PRTA Ireland
- Employees
- MGPI N/A
- PRTA N/A
- Industry
- MGPI Beverages (Production/Distribution)
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- MGPI Consumer Staples
- PRTA Health Care
- Exchange
- MGPI Nasdaq
- PRTA Nasdaq
- Market Cap
- MGPI 803.7M
- PRTA 765.2M
- IPO Year
- MGPI 1988
- PRTA N/A
- Fundamental
- Price
- MGPI $32.19
- PRTA $15.56
- Analyst Decision
- MGPI Buy
- PRTA Buy
- Analyst Count
- MGPI 6
- PRTA 8
- Target Price
- MGPI $70.67
- PRTA $46.00
- AVG Volume (30 Days)
- MGPI 327.8K
- PRTA 307.4K
- Earning Date
- MGPI 02-26-2025
- PRTA 02-20-2025
- Dividend Yield
- MGPI 1.50%
- PRTA N/A
- EPS Growth
- MGPI 9.02
- PRTA N/A
- EPS
- MGPI 4.82
- PRTA N/A
- Revenue
- MGPI $737,717,000.00
- PRTA $135,157,000.00
- Revenue This Year
- MGPI N/A
- PRTA $56.89
- Revenue Next Year
- MGPI N/A
- PRTA N/A
- P/E Ratio
- MGPI $6.67
- PRTA N/A
- Revenue Growth
- MGPI N/A
- PRTA 47.92
- 52 Week Low
- MGPI $31.81
- PRTA $11.70
- 52 Week High
- MGPI $92.52
- PRTA $31.03
- Technical
- Relative Strength Index (RSI)
- MGPI 36.86
- PRTA 59.65
- Support Level
- MGPI $32.12
- PRTA $13.69
- Resistance Level
- MGPI $33.92
- PRTA $15.09
- Average True Range (ATR)
- MGPI 1.00
- PRTA 0.91
- MACD
- MGPI 0.16
- PRTA 0.13
- Stochastic Oscillator
- MGPI 22.81
- PRTA 68.56
About MGPI MGP Ingredients Inc.
MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives most of its revenue from the Distillery Solutions segment.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).